Market Research Logo

Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (<35 years, 35 years, >35 years) – 2018 Edition: Forecast to 2022

Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (<35 years, 35 years, >35 years) – 2018 Edition: Forecast to 2022

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of global cervical cancer diagnostics market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (Below 35 years and 35 years & above), By Region (North America, Europe, Asia Pacific and Rest of the World) and By Country (U.S, Canada, Germany, U.K, China, India, Mexico and Brazil).

According to Azoth Analytics research report, “Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (<35 years, 35 years, >35 years) – 2018 Edition: Forecast to 2022”, global market is projected to display a modest growth represented by a CAGR of 5.69% during 2017 – 2022, chiefly driven by growing healthcare awareness and increasing expenditure in healthcare sector.

On account of growing urbanization, there has been rising awareness regarding the benefits of periodic screening for cervical cancer. Additionally, growing female population in concurrence with medical infrastructural developments in emerging economies has been instrumental in boosting the demand for cervical cancer diagnostics. Amongst the type of cervical cancer diagnostic tests, cytology based screening solutions such as Pap and HPV, held the majority market share of more than 50%, by value, in the year 2016. Moreover, HPV tests are gaining market share on account of advantageous characteristics such as reliable and accurate result, reasonable cost, longer time gap between tests, and so on. Among the regions, North America and Europe together represents the largest regional market for global cervical cancer diagnostics market, chiefly driven by high per capita expenditure on healthcare, as well as availability of advanced medical infrastructure.

The report titled, “Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (<35 years, 35 years, >35 years) – 2018 Edition: Forecast to 2022”, has covered and analysed the potential of cervical cancer diagnostics market across the globe and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global cervical cancer diagnostics market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022)

  • Global Cervical Cancer Diagnostics Market, By Value
  • Global Cervical Cancer Diagnostics Market, By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Value
  • Global Cervical Cancer Diagnostics Market, By Age Group (Below 35 years and 35 years and above), By Value
Regional Markets – North America, Europe, Asia Pacific and Rest of the World (Actual Period: 2012-2016, Forecast Period: 2017-2022)
  • Cervical Cancer Diagnostics Market, By Value
  • Cervical Cancer Diagnostics Market, By Type, By Value
  • Cervical Cancer Diagnostics Market, By Age Group, By Value
Country Analysis – U.S, Canada, U.K, Germany, China, India, Brazil and Mexico (Actual Period: 2012-2016, Forecast Period: 2017-2022)
  • Cervical Cancer Diagnostics Market, By Value
  • Cervical Cancer Diagnostics Market, By Type, By Value
  • Cervical Cancer Diagnostics Market, By Age Group, By Value
Other Report Highlights
  • Market Dynamics – Trends, Drivers, Restraints
  • Porter Five Force Analysis
  • SWOT Analysis
  • Supply Chain Analysis
  • Pricing Analysis
  • Product Benchmarking of Key Industry Players
  • Recent Product Approvals of Key Industry Players
  • Policy and Regulation
  • Company Analysis – Hologic, Roche, Abott Laboratories, Guided Therapeutics, Becton, Dickinson and Company, Qiagen, Quest Diagnostics, Arbor Vita Corporation.
  • Company Share Analysis
Customization of the Report

The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.


1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. Cervical Cancer Outlook
Table A: List of Abbreviations
Table B: Cervical Cancer Flowchart
Table C: Cervical Cancer Screening Recommendations
Table D: Cervical Cancer Diagnostics Segmentation Flowchart
5. Global Cervical Cancer Diagnostics Market: Growth and Forecast
5.1. By Value (2012-2016)
Table 1: Global Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million)
5.2. By Value (2017-2022)
Table 2: Global Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million)
Table 3: Healthcare Costs Per Capita, By Select Countries, 2015 (USD)
Table E: Medical Tourism Market Drivers
Table F: Medical Tourism Index, By Region and Top Destinations
Table 4: World Female Population Estimates, 2017 (In Millions)
Table 5: Age-Standardized Cervical Cancer Incidence Rate (per 100,000 women per year), By Region
Table 6: Top 10 Most Frequent Cancer in Females, World, (Age-standardised incidence rate per 100,000 women)
Table 7: Top 10 Most Frequent Cancer Deaths in Females, World, (Age-standardised incidence rate per 100,000 women)
Table G: Recent Company Acquisitions in Cervical Cancer Diagnostics Market
6. Global Cervical Cancer Diagnostics Market: An Analysis
6.1. Global Cervical Cancer Diagnostics Market Size, By Type
6.1.1. Global Cervical Cancer Diagnostics Market Size, By Type, 2016 (%)
Table 8: Global Cervical Cancer Diagnostics Market Size, By Type, 2016 (%)
6.1.2. Global Cervical Cancer Diagnostics Market Size, By Type, 2022 (%)
Table 9: Global Cervical Cancer Diagnostics Market Size, By Type, 2022 (%)
6.1.3. Global Pap Test Market, By Value (2012-2022)
Table 10: Global PAP Test Market, By Value, 2012-2016 (USD Million)
Table 11: Global PAP Test Market, By Value, Forecast, 2017-2022 (USD Million)
6.1.4. Global HPV Test Market, By Value (2012-2022)
Table 12: Global HPV Test Market, By Value, 2012-2016 (USD Million)
Table 13: Global HPV Test Market, By Value, Forecast, 2017-2022 (USD Million)
6.1.5. Global Colposcopy Market, By Value (2012-2022)
Table 14: Global Colposcopy Test Market, By Value, 2012-2016 (USD Million)
Table 15: Global Colposcopy Test Market, By Value, Forecast, 2017-2022 (USD Million)
6.1.6. Global Cervical Biopsies Market, By Value (2012-2022)
Table 16: Global Cervical Biopsies Market, By Value, 2012-2016 (USD Million)
Table 17: Global Cervical Biopsies Market, By Value, Forecast, 2017-2022, (USD Million)
6.2. Global Cervical Cancer Diagnostics Market Size, By Age Group
6.2.1. Global Cervical Cancer Diagnostics Market Size, By Age Group, 2016 (%)
Table 18: Global Cervical Cancer Diagnostics Market Size, By Age Group, 2016 (%)
6.2.2. Global Cervical Cancer Diagnostics Market Size, By Age Group, 2022 (%)
Table 19: Global Cervical Cancer Diagnostics Market Size, By Age Group, 2022 (%)
6.2.3. Global Cervical Cancer Diagnostics Market, By Age Group (Below 35 years), By Value (2012-2022)
Table 20: Global Cervical Cancer Diagnostics Market, By Age Group (Below 35 years), By Value, 2012-2016 (USD Million)
Table 21: Global Cervical Cancer Diagnostics Market, By Age Group (Below 35 years), By Value, Forecast, 2017-2022 (USD Million)
6.2.4. Global Cervical Cancer Diagnostics Market, By Age Group (35 years and above),
6.2.5. By Value (2012-2022)
Table 22: Global Cervical Cancer Diagnostics Market, By Age Group (35 years and above), By Value, 2012-2016 (USD Million)
Table 23: Global Cervical Cancer Diagnostics Market, By Age Group (35 years and above), By Value, Forecast, 2017-2022 (USD Million)
7. Global Cervical Cancer Diagnostics Market: Regional Analysis
7.1. Global Cervical Cancer Diagnostics Market Size, By Region: Breakdown (%)
7.1.1. Global Cervical Cancer Diagnostics Market Size, By Region, 2016 (%)
Table 24: Global Cervical Cancer Diagnostics Market Size, By Region, 2016 (%)
7.1.2. Global Cervical Cancer Diagnostics Market Size, By Region, 2022 (%)
Table 25: Global Cervical Cancer Diagnostics Market Size, By Region, 2022 (%)
7.2. North America Cervical Cancer Diagnostics Market: An Analysis
7.2.1. By Value (2012-2016)
Table 26: North America Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million)
7.2.2. By Value (2017-2022)
Table 27: North America Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million)
Table 28: North America Healthcare Cost Per Capita, By Select Country, 2016 (USD)
Table 29: North America GDP, 2012-2015 (USD Trillion)
Table 30: North America GDP, By Select Country, 2016 (USD Trillion)
Table 31: United States of America, Per Capita Expenditure on Healthcare, 2012-2016 (USD)
Table 32: Canada, Per Capita Expenditure on Healthcare, 2012-2016 (USD)
Table 33: United States of America, Female Population in the age group 15-64, 2012-2016
Table 34: Canada, Female Population in the age group 15-64, 2012-2016
Table H: HPV-Associated and HPV-Attributable Cancer Statistics, U.S, 2015
7.2.3. By Type, By Value (2012-2022)
Table 35: North America Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
7.2.4. By Age Group, By Value (2012-2022)
Table 36: North America Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
7.3. North America Cervical Cancer Diagnostics Market: Country Analysis (U.S and Canada)
7.3.1. U.S Cervical Cancer Diagnostics Market, By Value (2012-2022)
Table 37: U.S. Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)
Table 38: U.S Health Spending, By Service or Product, 2016 (%)
7.3.2. U.S Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)
Table 39: U.S Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
7.3.3. U.S Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)
Table 40: U.S Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
7.3.4. Canada Cervical Cancer Diagnostics Market, By Value (2012-2022)
Table 41: Canada Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)
7.3.5. Canada Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)
Table 42: Canada Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
7.3.6. Canada Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)
Table 43: Canada Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Table I: Major Players in cervical cancer diagnostics market in North America
Table 44: North America Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total)
Table 45: North America Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total)
7.4. Europe Cervical Cancer Diagnostics Market: An Analysis
7.4.1. By Value (2012-2016)
Table 46: Europe Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million)
7.4.2. By Value (2017-2022)
Table 47: Europe Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million)
Table J: Europe, Female Population aged 15+, By Region, 2017, (In Millions)
Table 48: Europe, GDP, By Select Country, 2016, (USD Billion)
Table 49: Europe Health Spending Per Capita, By Select Country, 2016 (USD)
Table 50: United Kingdom, Per Capita Expenditure on Healthcare, 2012-2016 (USD)
Table 51: Germany, Per Capita Expenditure on Healthcare, 2012-2016 (USD)
Table 52: United Kingdom, Female Population in the age group 15-64, 2012-2016
Table 53: Germany, Female Population in the age group 15-64, 2012-2016
Table 54: Europe Medical Technology Market Based on Manufacturer Prices, By Country, 2016 (%)
Table K: Major Players in cervical cancer diagnostics market in Europe
7.4.3. By Type, By Value (2012-2022)
Table 55: Europe Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
7.4.4. By Age Group, By Value (2012-2022)
Table 56: Europe Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
7.5. Europe Cervical Cancer Diagnostics Market: Country Analysis (Germany and U.K)
7.5.1. Germany Cervical Cancer Diagnostics Market, By Value (2012-2022)
Table 57: Germany Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)
7.5.2. Germany Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)
Table 58: Germany Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
7.5.3. Germany Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)
Table 59: Germany Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
7.5.4. U.K Cervical Cancer Diagnostics Market, By Value (2012-2022)
Table 60: U.K Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)
7.5.5. U.K Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)
Table 61: U.K Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
7.5.6. U.K Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)
Table 62: U.K Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Table 63: Europe Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total)
Table 64: Europe Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total)
7.6. APAC Cervical Cancer Diagnostics Market: An Analysis
7.6.1. By Value (2012-2016)
Table 65: APAC Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million)
7.6.2. By Value (2017-2022)
Table 66: APAC Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million)
Table 67: APAC, GDP, By Select Country, 2016, (USD Billion)
Table 68: APAC Health Expenditure Per Capita, Public and Private, By Select Country, 2016 (USD)
Table 69: China, Female Population in the age group 15-64, 2012-2016
Table 70: India, Female Population in the age group 15-64, 2012-2016
Table 71: India, Degree of Urbanization, 2012-2016 (in %)
Table 72: China, Degree of Urbanization, 2012-2016, (in %)
7.6.3. By Type, By Value (2012-2022)
Table 73: APAC Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
7.6.4. By Age Group, By Value (2012-2022)
Table 74: APAC Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
7.7. APAC Cervical Cancer Diagnostics Market: Country Analysis (China and India)
7.7.1. China Cervical Cancer Diagnostics Market, By Value (2012-2022)
Table 75: China Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)
7.7.2. China Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)
Table 76: China Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
7.7.3. China Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)
Table 77: China Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
7.7.4. India Cervical Cancer Diagnostics Market, By Value (2012-2022)
Table 78: India Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)
7.7.5. India Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)
Table 79: India Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
7.7.6. India Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)
Table 80: India Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Table 81: APAC Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total)
Table 82: APAC Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total)
7.8. ROW Cervical Cancer Diagnostics Market: An Analysis
7.8.1. By Value (2012-2016)
Table 83: ROW Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)
7.8.2. By Value (2017-2022)
Table 83: ROW Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million)
7.8.3. By Type, By Value (2012-2022)
Table 84: ROW Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
7.8.4. By Age Group, By Value (2012-2022)
Table 85: ROW Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
7.9. ROW Cervical Cancer Diagnostics Market: Country Analysis (Brazil and Mexico)
7.9.1. Brazil Cervical Cancer Diagnostics Market, By Value (2012-2022)
Table 86: Brazil Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)
Table 87: Brazil, Female Population in the age group 15-64, 2012-2016
Table 88: Brazil, Degree of Urbanization, 2012-2016 (in %)
7.9.2. Brazil Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)
Table 89: Brazil Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
7.9.3. Brazil Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)
Table 89: Brazil Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
7.9.4. Mexico Cervical Cancer Diagnostics Market, By Value (2012-2022)
Table 91: Mexico Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)
Table 92: Mexico, Female Population in the age group 15-64, 2012-2016
Table 93: Mexico, Degree of Urbanization, 2012-2016 (in %)
7.9.5. Mexico Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)
Table 94: Mexico Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
7.9.6. Mexico Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)
Table 95: Mexico Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Table 96: ROW Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total)
Table 97: ROW Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total)
8. Global Cervical Cancer Diagnostics Market Dynamics
8.1. Global Cervical Cancer Diagnostics Market Drivers
8.2. Global Cervical Cancer Diagnostics Market Restraints
9. Global Cervical Cancer Diagnostics Market Trends
10. Porter Five Force Analysis
11. SWOT Analysis
12. Supply Chain Analysis
13. Pricing Analysis
Table L: Pricing Analysis of PAP TEST
Table M: Pricing Analysis of HPV TEST
Table N: Pricing Analysis of Colposcopy Test
Table O: Pricing Analysis of Cervical Biopsy
14. Competitive Landscape
14.1. Company Share Analysis of Key Industry Players
Table 98: Global Cervical Cancer Diagnostics Market, By Company Share, 2016 (%)
Table P: Roche, Growth Strategy
14.2. Product Benchmarking of Key Industry Players
Table Q: Product Benchmarking of Key Industry Players, By Type
Table R: Product Benchmarking of Key Industry Players, By Type
14.3. Recent Product Approvals of Key Industry Players
Table S: Recent Product Approvals of Key Industry Players in Cervical Cancer Diagnostics Market
15. Policy and Regulatory Landscape
16. Company Profiles
16.1. Hologic
Table 99: Hologic, Revenue, 2013-2017 (USD Billion)
Table 100: Hologic, Revenue, By Geography, 2017 (%)
Table 101: Hologic, Revenue, By Segment, 2017 (%)
16.2. Abott Laboratories
Table 102: Abbott Laboratories, Revenue, 2012-2016 (USD Million)
Table 103: Abobott Laboratories, Revenue, By Segment, 2016 (%)
Table 104: Abbott, Revenue, By Geography, 2016 (%)
16.3. Roche
Table 105: Roche, Revenue, 2012-2016 (USD Million)
Table 106: Roche, Revenue, By Segment, 2016 (%)
Table 107: Roche, Revenue, By Geography, 2016 (%)
16.4. Guided Therapeutics
Table 108: Guided Therapeutics, Sales, 2012-2016 (USD thousands)
16.5. Becton, Dickinson and Company
Table 109: BD, Revenue, 2012-2016 (USD Million)
Table 110: BD, Revenue, By Geography, 2017 (%)
Table 111: BD, Revenue, By Segment, 2017 (%)
16.6. Qiagen
Table 112: Qiagen, Revenue, 2012-2016 (USD Millions)
Table 113: Qiagen, Revenue, By Geography, 2016 (%)
Table 114: Qiagen, Revenue, By Product Categories, 2016 (%)
16.7. Quest Diagnostics
Table 115: Quest Diagnostics, Revenue, 2012-2016 (USD Millions)
Table 116: Quest Diagnostics, Revenue, By Business Segments, 2016 (%)
16.8. Arbor Vita Corporation
17. About Us

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report